Cited by 146Memory and Neural MechanismsNicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice

Open access

Abstract

The effects of acute nicotine administration (0.09 mg/kg nicotine), chronic nicotine administration (6.3 mg/kg/d nicotine for 14 d), and withdrawal from chronic nicotine administration on fear conditioning in C57BL/6 mice were examined. Mice were trained using two coterminating conditioned stimulus (30 s; 85 dB white noise)–unconditioned stimulus (2 s; 0.57 mA foot shock) pairings and tested 24 h later for contextual and cued fear conditioning. Acute nicotine administration enhanced contextual fear conditioning, chronic nicotine administration had no effect on contextual fear conditioning, and withdrawal from chronic nicotine administration impaired contextual fear conditioning. Plasma nicotine concentrations were similar after acute and chronic treatment and were within the range reported for smokers. During withdrawal, concentrations of nicotine were undetectable. An acute dose of nicotine (0.09 mg/kg) during withdrawal from chronic nicotine treatment reversed withdrawal-associated deficits in contextual fear conditioning. The results suggest that tolerance to the effects of nicotine on contextual fear conditioning develops with chronic nicotine treatment at a physiologically relevant dose, and withdrawal from this chronic nicotine treatment is associated with impairments in contextual fear conditioning. These findings provide a model of how the effects of nicotine on learning may contribute to the development and maintenance of nicotine addiction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2853-05.2005

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 6

  1. 1999, Drug Metab Dispos, 27, 1448
  2. 1973, Psychol Reports, 32, 963, 10.2466/pr0.1973.32.3.963 · DOI
  3. 1983, J Pharmacol Exp Ther, 226, 817
  4. 1993, J Pharmacol Exp Ther, 266, 1268
  5. 1997, J Pharmacol Exp Ther, 283, 675
  6. 1984, Drug Metab Dispos, 12, 725

Cited by

Sorted by citations

Metadata

Authors
Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J.
Affiliations
  • Temple University (US)
  • Virginia Commonwealth University (US)
  • University of Pennsylvania (US)
Venue
The Journal of Neuroscience
Published
2005-09-21
Volume
25
Issue
38
Pages
8708-8713
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2088102722
Cited by
146
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 15 · 2015: 14 · 2014: 17 · 2013: 8 · 2012: 8
FWCI
4.30
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pennsylvania Department of Health
  • Temple University
  • National Institutes of Health (DA017949)
  • U.S. Public Health Service (P5084718)
  • National Institute on Drug Abuse (DA017949, R01DA017949, T32DA 07237, P5084718, T32DA007237)
  • National Cancer Institute (P5084718)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
nicotine, nicotine withdrawal, contextual fear conditioning, cued fear conditioning, chronic nicotine administration, acute nicotine administration, tolerance (pharmacology and immunology), nicotine dependence, C57BL/6 mice, plasma nicotine concentration, learning deficits
MeSH terms
Animals, Conditioning, Psychological, Fear, Male, Mice, Inbred C57BL, Nicotine, Substance Withdrawal Syndrome, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review